By proceeding, you agree to our Terms of Use and Privacy Policy.
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we've expanded to four full days in 2023, is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers. Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipment manufacturers, patient advocates, and more.
Brush up your knowledge of gene and cell therapy.
Learn about the most recent scientific research, keep abreast of emerging technology, and network with peers and industry professionals to advance your careers.
Partake in workshops, career fair, George Stamatoyannopoulos Memorial Lecture and Award presentation, symposium, sessions, revolving around the gene and cell therapy.
Hear from industry professionals and leaders about gene editing, gene therapy, cell therapy, RNA-based therapies, and gene delivery.
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals.
Very enjoyable conference but more food options should be there in the morning and lunch.
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tiss
Cytiva is a global life sciences leader with more than 7,000 associates across 40 countries dedicated to advancing and accelerating therapeutics.
Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront
Merck Life Sciences is a leader in biomarker immunoassays, including 200+ MILLIPLEX® multiplex kits with over 1,200 different analytes, for use with Luminex® instrumentation, an ultra-high sensitivity platform for Single Molecule Counting (SMC™), inc
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
For over 25 years, FUJIFILM Diosynth Biotechnology’s mission has been advancing tomorrow’s medicine.
AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO), with a relentless commitment to deliver the highest standard of service to our clients and partners.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific.
PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases.
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf.
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.
Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics.
Exothera is a viral vector contract manufacturing and development organization (CDMO) using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies.
Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.
Nexcelom Bioscience is a developer and marketer of image cytometry products for cell analysis in life science and biomedical research.
We have built a sector leading viral vector platform, including our lentiviral vector delivery system, LentiVector platform, which we leverage to develop in vivo and ex vivo products both in-house and with partners.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.